Aug 6, 2026, 01:02 by User Not Found

Clinical Research News | In the most recent episode of The Scope of Things podcast, Daphne Smyth, head of global regulatory programs at Veristat, joins the conversation to relay her three days at BioChina 2026 in Suzhou and what the North American and European markets can expect from Chinese drug development.

Aug 4, 2026, 01:01 by User Not Found

Clinical Research News | Fresenius expands its access to innovation networks through its own corporate venture capital fund; Draig accelerates pipeline of highly specific AMPA and GABAA receptor modulators; and more.

Aug 3, 2026, 09:29 by

Verista names seasoned healthcare and pharma services leader as CEO to drive strategic growth, innovation, and operational excellence.

Jul 30, 2026, 12:47 by

TrialAssure® announced today that its ANONYMIZE® platform has been selected by the European Medicines Agency (EMA) as an official anonymisation tool used within the Agency.

Jul 30, 2026, 01:01 by User Not Found

Clinical Research News | The findings of more than 150 randomized controlled trials provide ample evidence that early mobilization of patients with acute respiratory failure (ARF) in the intensive care unit (ICU) is both safe and beneficial. Surprisingly, also giving them extra protein—a strategy used successfully with frail and elderly patients—doesn’t appear to have any additive benefit.

Jul 29, 2026, 01:02 by User Not Found

Clinical Research News | Fresenius expands its access to innovation networks through its own corporate venture capital fund; Draig accelerates pipeline of highly specific AMPA and GABAA receptor modulators; and more.

Jul 28, 2026, 07:55 by

CluePoints, provider of leading statistical and AI-driven software solutions, has appointed Martin (Marty) Magazzolo as its new Chief Commercial Officer (CCO).

Jul 28, 2026, 01:00 by User Not Found

Clinical Research News | Parhelia Biosciences and Sirona Dx announce a strategic partnership; The University of Cincinnati and UC Health launched the Center for Alzheimer's and Neurodegenerative Diseases Research; and more.

Jul 28, 2026, 01:00 by User Not Found

Clinical Research News | Parhelia Biosciences and Sirona Dx announce a strategic partnership; The University of Cincinnati and UC Health launched the Center for Alzheimer's and Neurodegenerative Diseases Research; and more.

Jul 23, 2026, 08:27 by

Leadership expansion reinforces ELRIG's commitment to delivering impactful drug discovery initiatives and driving community-wide collaboration

Jul 23, 2026, 08:27 by

Jul 23, 2026, 01:01 by User Not Found

Clinical Research News | In the future, it may be possible for the physiological signals passively collected by a smartwatch to alert the wearer of a potential change in their cognitive state. Consumer electronics giant Samsung, for its part, has teamed up with the Neuroscape Center at the University of California San Francisco (UCSF) to explore the possibility of expanding the health- and fitness-tracking capabilities of its Galaxy Watch to assess functioning of the brain.

Jul 22, 2026, 07:53 by

Novo Nordisk has filed a lawsuit against Eli Lilly, claiming that Lilly’s GLP-1 advertising campaigns use outdated comparisons and mislead consumers about obesity and diabetes treatments. The dispute focuses on advertisements comparing Zepbound® and Mounjaro® with lower doses of Wegovy® and Ozempic®. Novo Nordisk is seeking removal of the campaigns and corrective advertising to ensure patients receive updated scientific information. The case highlights increasing competition between leading pharmaceutical companies in the fast-growing GLP-1 therapy market.

Jul 21, 2026, 09:13 by

New collaboration with PSGIMSR and SOPHAS strengthens education, research, and computational infrastructure for the next generation of clinical pharmacology and pharmacometrics leaders

Jul 21, 2026, 09:13 by

Eli Lilly and Company has announced a definitive agreement to acquire clinical-stage biotechnology company AtaiBeckley in a deal valued at up to $3.8 billion, including milestone-based payments. The acquisition significantly expands Lilly's neuroscience pipeline with innovative rapid-acting neuroplastogen therapies for treatment-resistant depression and other serious mental health disorders. The transaction highlights growing pharmaceutical investment in next-generation psychiatric medicines designed to deliver durable symptom relief through novel mechanisms of action.

Jul 21, 2026, 09:13 by

MIB Agents Osteosarcoma Alliance, a nonprofit dedicated to Making It Better for the osteosarcoma community through research, education and patient support, today announced that Katherine Azima has joined the organization as Co-Director of Scientific Programs. In this role, Azima will work alongside Christina Ip-Toma, Co-Director of Scientific Programs, until Ip-Toma retires at the end of the year, to help lead and expand MIB Agents' growing portfolio of scientific initiatives, fostering collaboration among researchers, clinicians, industry partners and patient advocates to accelerate progress in osteosarcoma research.

Jul 21, 2026, 09:13 by

Trajan Scientific and Medical (Trajan), a global developer and manufacturer of analytical, life sciences, and medical technologies, has announced that its Harpera™ Microbiopsy Punch is now FDA-registered for marketing in the US. Previously available in the country for investigational use only, the suture-free device can now be used by healthcare professionals across a broader range of clinical skin sampling applications, alongside clinical research and wellness programs. The registration responds to growing demand from healthcare and research organizations for patient-friendly sampling approaches, offering a minimally invasive alternative to traditional skin biopsy that reduces collection burden while preserving sample quality for modern molecular techniques. Healthcare professionals in the US now gain expanded access to a tool that supports dermatology, biomarker research, and precision medicine, with applications spanning molecular analysis, translational research, and longitudinal skin sampling.

Jul 21, 2026, 01:00 by User Not Found

Clinical Research News | Anthropic yesterday announced a focused call for applications for work on rare genetic diseases. Accepted applicants will receive up to $50,000 in Claude credits over six months, with the goal of building a community of researchers looking into how AI can reshape our understanding of rare disease.

Jul 17, 2026, 01:01 by User Not Found

Clinical Research News | The landscape of clinical data management (CDM) is becoming increasingly complex. As a BCG report notes, sponsors’ expectations are rising. They are looking for greater consistency in speed and quality, better technology, and improved implementations.

Jul 15, 2026, 01:01 by User Not Found

Clinical Research News | Patients with hereditary angioedema have reason to be optimistic that regulatory approval of a one-time, in vivo CRISPR gene-editing therapy for the sudden and severe swelling attacks associated with the rare genetic condition could come as early as next year. Lonvoguran ziclumeran (lonvo-z), as it is known, has been under development by Intellia Therapeutics for the past six years.